Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Dynein regulatory complex subunit 4 (DRC4) is a highly conserved coiled-coil scaffold protein that is a core component of the nexin-dynein regulatory complex (N-DRC), a structure required for the normal motility of cilia and flagella in eukaryotic cells[2][3][4]. DRC4, together with DRC1 and DRC2, forms the foundational scaffold of the N-DRC that links and stabilizes adjacent microtubule doublets in the axoneme, coordinates the activity of dynein motors, and regulates the generation of ciliary or flagellar beating[1][2][3]. DRC4 orthologs include human GAS8, mouse GAS11, and DRC4A/DRC4B in some protists[2][3][4]. Loss-of-function mutations in DRC4 or its orthologs have been directly associated with defects in ciliary motility, including primary ciliary dyskinesia in humans[2][4]. There are currently no direct drugs known to target DRC4, and it is primarily studied in the context of basic cell biology and genetic diseases of motility[4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Dynein regulatory complex subunit 4 (DRC4).